Back to search

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

Data up to Jan 2025

Published2006
Citations444
References45

Total Citations Per Year

Abstract

References (45)

Regulation of the mevalonate pathway

1990 • 5,282 citations

Statin-Associated Myopathy

2003 • 1,447 citations

Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties

2004 • 976 citations

Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs

2004 • 881 citations

A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)

1999 • 630 citations

Polymorphisms in OATP-C

2001 • 605 citations

Drug and Bile Acid Transporters in Rosuvastatin Hepatic Uptake: Function, Expression, and Pharmacogenetics

2006 • 585 citations

Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1

1999 • 546 citations

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics

2003 • 514 citations

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

2005 • 459 citations

Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans

2004 • 438 citations

Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors

2002 • 422 citations

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

2004 • 419 citations

Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil

2004 • 403 citations

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole*

1998 • 402 citations

Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells

2005 • 368 citations

Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug Interaction between Cerivastatin and Cyclosporin A

2003 • 344 citations

Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization

2002 • 342 citations

Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine

2004 • 320 citations

Genetic Polymorphisms of Human Organic Anion Transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): Allele Frequencies in the Japanese Population and Functional Analysis

2002 • 316 citations

Grapefruit juice—simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors*

1998 • 301 citations

Current overview of statin-induced myopathy

2004 • 295 citations

Evidence for inverse effects of OATP-C (SLC21A6) *5 and *1b haplotypes on pravastatin kinetics

2004 • 293 citations

Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations*

1998 • 287 citations

In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.

1997 • 274 citations

Plasma concentrations of active simvastatin acid are increased by gemfibrozil

2000 • 258 citations

Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.

1990 • 240 citations

Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes.

2001 • 211 citations

DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1

2004 • 206 citations

Human Hepatobiliary Transport of Organic Anions Analyzed by Quadruple-Transfected Cells

2005 • 200 citations

Lipid-lowering response to statins is affected by CYP3A5 polymorphism

2004 • 196 citations

Clinical Pharmacokinetics and Practical Applications of Simvastatin

1993 • 182 citations

The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6

2003 • 180 citations

Effect of () variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers

2005 • 171 citations

Effect of Genetic Polymorphism of OATP-C (SLCO1B1) on Lipid-Lowering Response to HMG-CoA Reductase Inhibitors

2004 • 144 citations

Plasma Concentration Profiles of Simvastatin 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitory Activity in Kidney Transplant Recipients with and without Ciclosporin

1993 • 138 citations

Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17

2005 • 127 citations

Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.

1999 • 124 citations

Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population

2006 • 118 citations

Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport

2005 • 96 citations

A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro.

2001 • 86 citations

Microsample Determination of Lovastatin and its Hydroxy Acid Metabolite in Mouse and Rat Plasma by Liquid Chromatography/Ionspray Tandem Mass Spectrometry

1997 • 53 citations

3-Hydroxy-3-methylglutaryl–coenzyme a reductase inhibitors (statins) and genetic variability (single nucleotide polymorphisms) in a hepatic drug uptake transporter: what's it all about?

2004 • 52 citations

Inhibition of rhodamine 123 secretion by cyclosporin A as a model of P-glycoprotein mediated transport in liver.

1994 • 31 citations

OATP-C(OATP01B1)*15 is associated with statin-induced myopathy in hypercholesterolemic patients

2005 • 25 citations

Cited By (0)

Loading...
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid (2006) – Pharmacogenetics and Genomics | Metascience Observatory Explorer